SOX11 and breast carcinoma: We measured levels of melanoma inhibitory activity (MIA), encoded by a gene in the PAM50 test, which are characteristically high in basal‐like breast cancer, and are decreased upon small interfering RNA‐mediated knockdown of SOX11 in breast cancer cells, in a recent study 25.